From the Division of Plastic and Reconstructive Surgery, Stanford University, Palo Alto.
Stanford University School of Medicine, Stanford, CA.
Ann Plast Surg. 2022 May 1;88(4 Suppl 4):S343-S347. doi: 10.1097/SAP.0000000000003081. Epub 2022 Feb 21.
As healthcare spending within the United States grows, payers have attempted to curb spending through higher cost sharing for patients. For families attempting to balance financial obligations with their children's surgical needs, high cost sharing could place families in difficult situations, deciding between life-altering surgery and bankruptcy. We aim to investigate trends in patient cost sharing and provider payments for cleft lip and palate repair.
The IBM® MarketScan® Commercial Database was queried to extract patients younger than 18 years who underwent primary or secondary cleft lip and/or palate repair from 2007 to 2016. Financial variables included gross payments to the provider (facility and/or physician), net payment as reported by the carrier, coordination of benefits and other savings, and the beneficiary contribution, which consisted of patients' coinsurance, copay, and deductible payments. Linear regression was used to evaluate trends in payments over time. Poisson regression was used to trend the proportion of patients with a nonzero beneficiary contribution. All financial values were adjusted to 2016 dollars per the consumer price index to account for inflation.
The sample included 6268 cleft lip and 9118 cleft palate repair episodes. Total provider payments increased significantly from 2007 to 2016 for patients undergoing cleft lip (median, $2527.33 vs $5116.30, P 0.008) and palate ($1766.13 vs $3511.70, P < 0.001) repair. Beneficiary contribution also increased significantly for both cleft lip ($155.75 vs $193.31, P < 0.001) and palate ($124.37 vs $183.22, P < 0.001) repair, driven by an increase in deductibles ( P < 0.002). The proportion of cleft palate patients with a nonzero beneficiary contribution increased yearly by 1.6% ( P = 0.002). Higher provider payments and beneficiary contributions were found in the Northeast ( P < 0.001) and South ( P < 0.011), respectively, for both cleft lip and palate repair.
The US national data demonstrate that for commercially insured patients with cleft lip and/or palate, there has been a trend toward higher patient cost sharing, most pronounced in the South. This suggests that patients are bearing an increased cost burden while provider payments are simultaneously accelerating. Additional studies are needed to understand the impact of increased cost sharing on parents' decision to pursue cleft lip and/or palate repair for their children.
随着美国医疗保健支出的增长,支付方试图通过提高患者的自付费用来控制支出。对于那些既要平衡家庭经济负担,又要满足孩子手术需求的家庭来说,高昂的自付费用可能会使他们陷入困境,不得不面临改变生活的手术和破产之间的抉择。我们旨在调查唇腭裂修复手术中患者自付费用和医疗机构支付费用的变化趋势。
使用 IBM® MarketScan®商业数据库检索了 2007 年至 2016 年间接受过唇裂和/或腭裂一期或二期修复术的 18 岁以下患者数据。财务变量包括向医疗机构(医院和/或医生)支付的总金额、保险公司报告的净付款额、共付额和其他储蓄额,以及受益人的自付额,包括患者的共同保险额、共付额和免赔额支付额。使用线性回归来评估随时间推移的支付趋势。使用泊松回归来分析有非零受益人的患者比例的变化趋势。所有财务数据均根据消费者物价指数调整为 2016 年的美元,以考虑通货膨胀因素。
该样本包括 6268 例唇裂和 9118 例腭裂修复术。与 2007 年相比,2016 年接受唇裂(中位数分别为 2527.33 美元和 5116.30 美元,P<0.008)和腭裂(中位数分别为 1766.13 美元和 3511.70 美元,P<0.001)修复术的患者的医疗机构支付总额显著增加。唇裂(从 155.75 美元增加到 193.31 美元,P<0.001)和腭裂(从 124.37 美元增加到 183.22 美元,P<0.001)的受益人的自付额也显著增加,这主要是由于免赔额的增加(P<0.002)。每年有唇腭裂患者的受益人为非零贡献者的比例增加 1.6%(P=0.002)。在东北地区(P<0.001)和南部地区(P<0.011),无论是唇裂还是腭裂修复术,医疗机构支付额和受益人的自付额都较高。
美国全国数据表明,对于有商业保险的唇裂和/或腭裂患者,患者自付费用呈上升趋势,在南部地区最为明显。这表明患者的负担成本在增加,而医疗机构的支付额也在同时加速增长。需要进一步研究以了解增加自付费用对父母决定为孩子进行唇腭裂修复术的影响。